INFUSYSTEMS HLDG.DL-0001
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of va… Read more
Market Cap & Net Worth: INFUSYSTEMS HLDG.DL-0001 (1TZ)
INFUSYSTEMS HLDG.DL-0001 (F:1TZ) has a market capitalization of $172.21 Million (€167.77 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #16952 globally and #1761 in its home market, demonstrating a 2.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INFUSYSTEMS HLDG.DL-0001's stock price €8.25 by its total outstanding shares 20336183 (20.34 Million).
INFUSYSTEMS HLDG.DL-0001 Market Cap History: 2021 to 2026
INFUSYSTEMS HLDG.DL-0001's market capitalization history from 2021 to 2026. Data shows change from $304.77 Million to $172.21 Million (-14.86% CAGR).
INFUSYSTEMS HLDG.DL-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INFUSYSTEMS HLDG.DL-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1TZ by Market Capitalization
Companies near INFUSYSTEMS HLDG.DL-0001 in the global market cap rankings as of March 19, 2026.
Key companies related to INFUSYSTEMS HLDG.DL-0001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
INFUSYSTEMS HLDG.DL-0001 Historical Marketcap From 2021 to 2026
Between 2021 and today, INFUSYSTEMS HLDG.DL-0001's market cap moved from $304.77 Million to $ 172.21 Million, with a yearly change of -14.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €172.21 Million | +11.49% |
| 2025 | €154.47 Million | -2.63% |
| 2024 | €158.65 Million | -20.42% |
| 2023 | €199.35 Million | +22.44% |
| 2022 | €162.82 Million | -46.58% |
| 2021 | €304.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of INFUSYSTEMS HLDG.DL-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $172.21 Million USD |
| MoneyControl | $172.21 Million USD |
| MarketWatch | $172.21 Million USD |
| marketcap.company | $172.21 Million USD |
| Reuters | $172.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.